Showing of 3 results
UH Harrington Heart & Vascular Institute is first in Ohio to enroll postpartum women in study of cardiomyopathy.
Heart patient DeAnn Bartram has a good prognosis after genetic testing helps identify her hereditary arrhythmogenic cardiomyopathy – a condition that claimed the lives of her two sisters.
Just three days after being fitted with a LifeVest defibrillator, Glynn Crawford experienced a life-threatening abnormal heart rhythm. The wearable device detected this and shocked him back to life.